• Those six months of age and older are urged to obtain the vaccines.

• Individuals receiving solid organ transplants between 18 and 64 can now select off-label for an adjuvanted or high-dose flu vaccine.

• In addition, the Advisory Committee for Immunization Practices (ACIP) overwhelmingly decided to suggest Merck's novel 21-valent (21-strain) pneumococcal vaccine as a choice for persons 65 years of age and older who have not had a vaccination or whose immunization history is unknown.

• Additionally, the committee advised a single dose of the vaccine for patients with specific underlying medical disorders ages 19 to 64.

• This recommendation applied to individuals who had not gotten a dose of the pneumococcal conjugate vaccination and those who began their series with PCV13 but had not obtained all necessary doses of PPSV23.

Click here to read more.